Results 241 to 250 of about 70,715 (255)

Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations

Cells, 2022
Jonathan Ravid, Orly Leiva, Vipul Chitalia   +2 more
exaly  

Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis

European Journal of Gastroenterology & Hepatology, 2008
COLAIZZO D, AMITRANO L, GUARDASCIONE MA, BALZANO A, MARGAGLIONE, MAURIZIO   +4 more
openaire   +2 more sources

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic and Medicinal Chemistry Letters, 2007
Adam Golebiowski, Biswanath De, Roger G Bookland   +2 more
exaly  

Targeting the Janus Kinase Family in Autoimmune Skin Diseases

Frontiers in Immunology, 2019
Michael Howell, Fiona Kuo, Howell Michael D   +2 more
exaly  

INHIBITORS AND DEGRADERS OF JANUS KINASE 2

2022
LAWRENCE NICHOLAS, LAWRENCE HARSHANI, SCHÖNBRUNN ERNST, REUTHER GARY   +3 more
openaire   +1 more source

The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature

Journal of Cutaneous Medicine and Surgery, 2019
Melinda Gooderham, Nicole Relke
exaly  

Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

Pharmacological Research, 2016
Robert Roskoski
exaly  

Comparison of Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis: A Systemic Literature Review

Immunotherapy, 2019
Matthew A Türk
exaly  

Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature

Journal of Dermatological Treatment, 2017
Alireza Firooz, Aniseh Samadi, Mansour Nassiri Kashani   +2 more
exaly  

Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects

Leukemia and Lymphoma, 2011
Ludovica Riera, Roberto Chiarle, Alberto Bardelli   +2 more
exaly